Lisdexamfetamine Dimesylate Capsule — FDA Drug Shortage
The FDA lists a drug shortage record for Lisdexamfetamine Dimesylate Capsule (capsule) from Mylan Pharmaceuticals Inc., A Viatris Company with status Current. The shortage was first posted on Jul 14, 2023.
Shortage details
- Status
- Current
- Company
- Mylan Pharmaceuticals Inc., A Viatris Company
- Package NDC
- 0378-6858-77
- Dosage Form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)
- Initial Posting
- Jul 14, 2023